Free Trial

Adagio Medical (ADGM) Competitors

Adagio Medical logo
$0.86 -0.04 (-4.48%)
Closing price 05/15/2026 04:00 PM Eastern
Extended Trading
$0.87 +0.01 (+1.58%)
As of 05/15/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ADGM vs. PPYA, BYNO, CHPG, BVC, and HNNA

Should you buy Adagio Medical stock or one of its competitors? MarketBeat compares Adagio Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Adagio Medical include Papaya Growth Opportunity Corp. I (PPYA), byNordic Acquisition (BYNO), Championsgate Acquisition (CHPG), Bitventures (BVC), and Hennessy Advisors (HNNA). These companies are all part of the "trading" industry.

How does Adagio Medical compare to Papaya Growth Opportunity Corp. I?

Adagio Medical (NASDAQ:ADGM) and Papaya Growth Opportunity Corp. I (NASDAQ:PPYA) are both small-cap trading companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, institutional ownership, media sentiment, risk and dividends.

Adagio Medical has a beta of -0.14, indicating that its stock price is 114% less volatile than the broader market. Comparatively, Papaya Growth Opportunity Corp. I has a beta of -0.03, indicating that its stock price is 103% less volatile than the broader market.

48.1% of Adagio Medical shares are owned by institutional investors. Comparatively, 22.4% of Papaya Growth Opportunity Corp. I shares are owned by institutional investors. 5.2% of Adagio Medical shares are owned by company insiders. Comparatively, 96.2% of Papaya Growth Opportunity Corp. I shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Adagio Medical presently has a consensus target price of $3.50, indicating a potential upside of 306.79%. Given Adagio Medical's stronger consensus rating and higher probable upside, analysts plainly believe Adagio Medical is more favorable than Papaya Growth Opportunity Corp. I.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Adagio Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Papaya Growth Opportunity Corp. I
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Papaya Growth Opportunity Corp. I's return on equity of 0.00% beat Adagio Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Adagio MedicalN/A -382.50% -64.98%
Papaya Growth Opportunity Corp. I N/A N/A -10.11%

In the previous week, Adagio Medical had 5 more articles in the media than Papaya Growth Opportunity Corp. I. MarketBeat recorded 5 mentions for Adagio Medical and 0 mentions for Papaya Growth Opportunity Corp. I. Papaya Growth Opportunity Corp. I's average media sentiment score of 0.00 beat Adagio Medical's score of -0.23 indicating that Papaya Growth Opportunity Corp. I is being referred to more favorably in the news media.

Company Overall Sentiment
Adagio Medical Neutral
Papaya Growth Opportunity Corp. I Neutral

Papaya Growth Opportunity Corp. I has lower revenue, but higher earnings than Adagio Medical. Papaya Growth Opportunity Corp. I is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Adagio Medical$600K31.85-$25.08M-$1.53N/A
Papaya Growth Opportunity Corp. IN/AN/A$1.88M-$0.90N/A

Summary

Adagio Medical and Papaya Growth Opportunity Corp. I tied by winning 7 of the 14 factors compared between the two stocks.

How does Adagio Medical compare to byNordic Acquisition?

byNordic Acquisition (NASDAQ:BYNO) and Adagio Medical (NASDAQ:ADGM) are both small-cap trading companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, profitability, media sentiment, valuation and risk.

byNordic Acquisition has a beta of -0.02, indicating that its share price is 102% less volatile than the broader market. Comparatively, Adagio Medical has a beta of -0.14, indicating that its share price is 114% less volatile than the broader market.

32.9% of byNordic Acquisition shares are held by institutional investors. Comparatively, 48.1% of Adagio Medical shares are held by institutional investors. 2.6% of byNordic Acquisition shares are held by insiders. Comparatively, 5.2% of Adagio Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Adagio Medical has a consensus target price of $3.50, indicating a potential upside of 306.79%. Given Adagio Medical's stronger consensus rating and higher probable upside, analysts plainly believe Adagio Medical is more favorable than byNordic Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
byNordic Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Adagio Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

byNordic Acquisition's return on equity of 0.00% beat Adagio Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
byNordic AcquisitionN/A N/A N/A
Adagio Medical N/A -382.50%-64.98%

In the previous week, Adagio Medical had 5 more articles in the media than byNordic Acquisition. MarketBeat recorded 5 mentions for Adagio Medical and 0 mentions for byNordic Acquisition. byNordic Acquisition's average media sentiment score of 0.00 beat Adagio Medical's score of -0.23 indicating that byNordic Acquisition is being referred to more favorably in the media.

Company Overall Sentiment
byNordic Acquisition Neutral
Adagio Medical Neutral

byNordic Acquisition has higher earnings, but lower revenue than Adagio Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
byNordic AcquisitionN/AN/AN/AN/AN/A
Adagio Medical$600K31.85-$25.08M-$1.53N/A

Summary

Adagio Medical beats byNordic Acquisition on 7 of the 11 factors compared between the two stocks.

How does Adagio Medical compare to Championsgate Acquisition?

Championsgate Acquisition (NASDAQ:CHPG) and Adagio Medical (NASDAQ:ADGM) are both small-cap trading companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, risk, earnings, dividends and media sentiment.

48.1% of Adagio Medical shares are owned by institutional investors. 5.2% of Adagio Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Adagio Medical has a consensus target price of $3.50, indicating a potential upside of 306.79%. Given Adagio Medical's stronger consensus rating and higher possible upside, analysts plainly believe Adagio Medical is more favorable than Championsgate Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Championsgate Acquisition
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Adagio Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

In the previous week, Adagio Medical had 3 more articles in the media than Championsgate Acquisition. MarketBeat recorded 5 mentions for Adagio Medical and 2 mentions for Championsgate Acquisition. Championsgate Acquisition's average media sentiment score of 1.62 beat Adagio Medical's score of -0.23 indicating that Championsgate Acquisition is being referred to more favorably in the media.

Company Overall Sentiment
Championsgate Acquisition Very Positive
Adagio Medical Neutral

Championsgate Acquisition's return on equity of 0.00% beat Adagio Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Championsgate AcquisitionN/A N/A N/A
Adagio Medical N/A -382.50%-64.98%

Championsgate Acquisition has higher earnings, but lower revenue than Adagio Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Championsgate AcquisitionN/AN/AN/AN/AN/A
Adagio Medical$600K31.85-$25.08M-$1.53N/A

Summary

Adagio Medical beats Championsgate Acquisition on 7 of the 10 factors compared between the two stocks.

How does Adagio Medical compare to Bitventures?

Bitventures (NASDAQ:BVC) and Adagio Medical (NASDAQ:ADGM) are both small-cap trading companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, risk, earnings, dividends and media sentiment.

Bitventures has a beta of -1.06, indicating that its stock price is 206% less volatile than the broader market. Comparatively, Adagio Medical has a beta of -0.14, indicating that its stock price is 114% less volatile than the broader market.

48.1% of Adagio Medical shares are owned by institutional investors. 84.6% of Bitventures shares are owned by insiders. Comparatively, 5.2% of Adagio Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Adagio Medical has a consensus target price of $3.50, indicating a potential upside of 306.79%. Given Adagio Medical's stronger consensus rating and higher possible upside, analysts plainly believe Adagio Medical is more favorable than Bitventures.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bitventures
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Adagio Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

In the previous week, Adagio Medical had 3 more articles in the media than Bitventures. MarketBeat recorded 5 mentions for Adagio Medical and 2 mentions for Bitventures. Bitventures' average media sentiment score of 0.59 beat Adagio Medical's score of -0.23 indicating that Bitventures is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bitventures
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Adagio Medical
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Bitventures' return on equity of 0.00% beat Adagio Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
BitventuresN/A N/A N/A
Adagio Medical N/A -382.50%-64.98%

Bitventures has higher revenue and earnings than Adagio Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bitventures$28.02M3.12-$5.37MN/AN/A
Adagio Medical$600K31.85-$25.08M-$1.53N/A

Summary

Adagio Medical beats Bitventures on 7 of the 13 factors compared between the two stocks.

How does Adagio Medical compare to Hennessy Advisors?

Adagio Medical (NASDAQ:ADGM) and Hennessy Advisors (NASDAQ:HNNA) are both small-cap trading companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

Adagio Medical has a beta of -0.14, indicating that its stock price is 114% less volatile than the broader market. Comparatively, Hennessy Advisors has a beta of 0.59, indicating that its stock price is 41% less volatile than the broader market.

Hennessy Advisors has higher revenue and earnings than Adagio Medical. Adagio Medical is trading at a lower price-to-earnings ratio than Hennessy Advisors, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Adagio Medical$600K31.85-$25.08M-$1.53N/A
Hennessy Advisors$35.54M2.21$9.96M$1.059.45

Adagio Medical currently has a consensus target price of $3.50, suggesting a potential upside of 306.79%. Given Adagio Medical's stronger consensus rating and higher possible upside, research analysts plainly believe Adagio Medical is more favorable than Hennessy Advisors.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Adagio Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Hennessy Advisors
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Adagio Medical and Adagio Medical both had 5 articles in the media. Hennessy Advisors' average media sentiment score of -0.02 beat Adagio Medical's score of -0.23 indicating that Hennessy Advisors is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Adagio Medical
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Hennessy Advisors
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Hennessy Advisors has a net margin of 25.40% compared to Adagio Medical's net margin of 0.00%. Hennessy Advisors' return on equity of 8.53% beat Adagio Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Adagio MedicalN/A -382.50% -64.98%
Hennessy Advisors 25.40%8.53%5.25%

48.1% of Adagio Medical shares are held by institutional investors. Comparatively, 10.3% of Hennessy Advisors shares are held by institutional investors. 5.2% of Adagio Medical shares are held by company insiders. Comparatively, 36.0% of Hennessy Advisors shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Hennessy Advisors beats Adagio Medical on 10 of the 15 factors compared between the two stocks.

Get Adagio Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADGM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ADGM vs. The Competition

MetricAdagio MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$20.01M$6.75B$6.43B$12.48B
Dividend YieldN/A1.75%2.80%5.25%
P/E Ratio-0.5649.1120.3825.24
Price / Sales31.8580.07566.1982.25
Price / CashN/A24.2143.0456.04
Price / Book3.316.499.876.90
Net Income-$25.08M$158.34M$3.57B$334.66M
7 Day Performance-11.75%-2.95%0.31%0.13%
1 Month Performance-41.86%-4.36%-1.27%1.11%
1 Year Performance-27.08%-4.45%33.54%30.62%

Adagio Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADGM
Adagio Medical
2.1559 of 5 stars
$0.86
-4.5%
$3.50
+306.8%
-29.5%$20.01M$600KN/A87
PPYA
Papaya Growth Opportunity Corp. I
N/A$11.01
flat
N/AN/A$90.71MN/AN/A3
BYNO
byNordic Acquisition
N/A$12.65
flat
N/A+5.4%$90.16MN/AN/AN/A
CHPG
Championsgate Acquisition
N/A$10.31
-0.2%
N/AN/A$89.78MN/AN/A2
BVC
Bitventures
0.8348 of 5 stars
$10.44
-4.1%
N/AN/A$88.54M$28.02MN/A6

Related Companies and Tools


This page (NASDAQ:ADGM) was last updated on 5/16/2026 by MarketBeat.com Staff.
From Our Partners